Jubilant Life Sciences Ltd (JUBILANT) - Financial and Strategic SWOT Analysis Review

  • ID: 4398190
  • SWOT Analysis
  • 58 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Atul Ltd
  • BASF India Ltd
  • Divi's Laboratories Ltd
  • Hetero Drugs Ltd
  • Tata Chemicals Ltd
  • MORE
Jubilant Life Sciences Ltd (JUBILANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights:

Jubilant Life Sciences Ltd (Jubilant) is an integrated pharmaceutical and life sciences company that provides pharmaceuticals, life science ingredients and drug discovery solutions. The company portfolio includes radiopharmaceuticals, allergy therapy products, active pharmaceutical ingredients (APIs), solid dosage formulations, life science chemicals, nutritional products, fine ingredients, advance intermediates and crop science ingredients. It also provides contract manufacturing of sterile injectables and drug discovery and development services. The company caters its products and services to customers across India, North America, Canada, Europe and China. It owns and operates cGMP compliant manufacturing facilities, and research and development centers in India, the US and Canada. Jubilant is headquartered in Noida, Uttar Pradesh, India.

Jubilant Life Sciences Ltd Key Recent Developments

Aug 21,2017: Jubilant Receives NDA Approval for Drax Exametazime
Jul 18,2017: Jubilant Life Sciences: Q1 FY2018 Result
Jul 18,2017: Jubilant Reports Q1 FY2018 Revenue of Rs. 1,596 Crore, UP 10% YOY Pharma Segment Records Highest Ever Sales Ebitda of Rs. 344 Crore and Margins of 21.6%; Pat of Rs. 147 Crore
Jun 01,2017: Jubilant Life Sciences Provides Update on Gajraula Manufacturing Unit
May 24,2017: Jubilant Life Sciences Announces Appointment of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Atul Ltd
  • BASF India Ltd
  • Divi's Laboratories Ltd
  • Hetero Drugs Ltd
  • Tata Chemicals Ltd
  • MORE
Section 1 - About the Company
Jubilant Life Sciences Ltd - Key Facts
Jubilant Life Sciences Ltd - Key Employees
Jubilant Life Sciences Ltd - Key Employee Biographies
Jubilant Life Sciences Ltd - Key Operational Employees
Jubilant Life Sciences Ltd - Major Products and Services
Jubilant Life Sciences Ltd - History
Jubilant Life Sciences Ltd - Company Statement
Jubilant Life Sciences Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

Section 2 - Company Analysis
Jubilant Life Sciences Ltd - Business Description
Jubilant Life Sciences Ltd - Corporate Strategy
Jubilant Life Sciences Ltd - SWOT Analysis
SWOT Analysis - Overview
Jubilant Life Sciences Ltd - Strengths
Jubilant Life Sciences Ltd - Weaknesses
Jubilant Life Sciences Ltd - Opportunities
Jubilant Life Sciences Ltd - Threats
Jubilant Life Sciences Ltd - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Jubilant Life Sciences Ltd, Recent Deals Summary

Section 5 - Company’s Recent Developments
Aug 21, 2017: Jubilant Receives NDA Approval for Drax Exametazime
Jul 18, 2017: Jubilant Life Sciences: Q1 FY2018 Result
Jul 18, 2017: Jubilant Reports Q1 FY2018 Revenue of Rs. 1,596 Crore, UP 10% YOY Pharma Segment Records Highest Ever Sales Ebitda of Rs. 344 Crore and Margins of 21.6%; Pat of Rs. 147 Crore
Jun 01, 2017: Jubilant Life Sciences Provides Update on Gajraula Manufacturing Unit
May 24, 2017: Jubilant Life Sciences Announces Appointment of Directors
May 23, 2017: Jubilant Life Sciences Reports Total RevenueOf INR26.2 Billion In Fiscal 2017
Feb 07, 2017: Jubilant Reports Strong Performance In Q3 FY17; Sales At Rs. 1,492 Crore, Up By 7% YOY EBITDA At Rs. 337 Crore; Up 9% YOY With Margins Of 22.6%; PAT At Rs. 120 Crore
Jan 25, 2017: Jubilant Life Sciences is now Responsible Care 14001: 2013 certified
Jan 04, 2017: Jubilant Life Sciences Announces Signing Of Long Term Contracts In Radiopharma Busines
Dec 20, 2016: Jubilant Life Sciences announces price increase of up to 15% for Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide)

Section 6 - Appendix
Methodology
Ratio Definitions

About the Publisher
Contact Us
Disclaimer

List of Tables
Jubilant Life Sciences Ltd, Key Facts
Jubilant Life Sciences Ltd, Key Employees
Jubilant Life Sciences Ltd, Key Employee Biographies
Jubilant Life Sciences Ltd, Key Operational Employees
Jubilant Life Sciences Ltd, Major Products and Services
Jubilant Life Sciences Ltd, History
Jubilant Life Sciences Ltd, Other Locations
Jubilant Life Sciences Ltd, Subsidiaries
Jubilant Life Sciences Ltd, Joint Venture
Jubilant Life Sciences Ltd, Key Competitors
Jubilant Life Sciences Ltd, Ratios based on current share price
Jubilant Life Sciences Ltd, Annual Ratios
Jubilant Life Sciences Ltd, Annual Ratios (Cont
Jubilant Life Sciences Ltd, Annual Ratios (Cont
Jubilant Life Sciences Ltd, Interim Ratios
Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Jubilant Life Sciences Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Jubilant Life Sciences Ltd, Performance Chart (2013 - 2017)
Jubilant Life Sciences Ltd, Ratio Charts
Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceutical Industries Ltd
  • Tata Chemicals Ltd
  • Hetero Drugs Ltd
  • Dr. Reddy's Laboratories Ltd
  • Divi's Laboratories Ltd
  • BASF India Ltd
  • Atul Ltd
  • Aditya Birla Chemicals (India) Limited
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll